Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1223
Delayed Data
As of Jul 22
 -0.0034 / -2.70%
Today’s Change
0.06
Today|||52-Week Range
0.21
+51.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues47.0K23.0K27.0K39.0K
 
 
 
 
 
Cost of Goods Sold221.0K61.0K5.0K103.0K
 
 
 
 
 
Depreciation And Amortization286.0K292.0K361.0K330.0K
 
 
 
 
 
 
Operating ExpensesGross Income-460.0K-330.0K-339.0K-394.0K
 
 
 
 
 
General Expenses4.4M3.7M2.5M3.3M
 
 
 
 
 
Research And Development2.4M2.0M957.0K1.0M
 
 
 
 
 
Total Operating Expenses4.9M4.0M2.9M3.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-4.0M-2.8M-3.7M
 
 
 
 
 
Interest Expense On Debt0.001.0K0.000.00
 
 
Other Expenses0.000.000.001.5M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.8M-3.8M-3.1M-2.2M
 
 
 
 
 
Net Income-4.8M-3.8M-3.1M-2.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS236.1M246.8M247.6M247.6M
 
 
 
 
 
Shares To Calculate EPS Diluted236.1M246.8M247.6M247.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.01-$0.01
 
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.01-$0.01